Nrf2-siRNA Enhanced the Anti-Tumor Effects of As2O3 in 5-Fluorouracil-Resistant Hepatocellular Carcinoma by Inhibiting HIF-1α/HSP70 Signaling
DOI: https://doi.org/10.2147/JHC.S388077
2022-12-21
Journal of Hepatocellular Carcinoma
Abstract:Xuhua Duan, &ast Wenze Xu, &ast Hao Li, Manzhou Wang, Wenhui Wang, Huibin Lu, Yancang Zhang, Xinwei Han Department of Interventional Radiology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yancang Zhang; Xinwei Han, Department of Interventional Radiology, The First Affiliated Hospital, Zhengzhou University, No. 1, East Jian She Road, People's Republic of China, 450052, Tel +86-371-66278081, Email ; Purpose: Chemoresistance is a major factor contributing to the failure of cancer treatment. The conventional chemotherapy agent 5-fluorouracil (5-FU) has been used for cancer treatment for decades. However, its use is limited in the treatment of hepatocellular carcinoma (HCC) due to acquired resistance. Nrf2 (NF-E2-related factor 2) is known to be associated with drug resistance across a wide range of cancer types. Also, since arsenic trioxide (As 2 O 3 ) showed antitumor effects on HCC, the purpose of this study was to determine whether As 2 O 3 and Nrf2-siRNA could inhibit HCC synergistically. Methods: We generated two separate 5-FU-resistant HCC cell lines (SNU-387/5-FU and Hep3B/5-FU). Western blotting was used to determine protein levels. An efficient lentiviral delivery system was used to establish stable knockdown or overexpression of Nrf2 and HIF-1α. In vitro and in vivo analyses of the effects of Nrf2 gene knockdown and As 2 O 3 on 5-FU-resistant HCC cells were conducted. Results: The expression of Nrf2 was higher in the 5-FU-resistant HCC cell lines than in the parental cell lines. When coupled with Nrf2 knockdown, As 2 O 3 treatment significantly decreased 5-FU-resistant SNU-387 and Hep3B cell viability, migration, and invasion, inactivated HIF-1α/HSP70 signaling, inhibited anti-apoptotic B-cell lymphoma (Bcl-2) activity, and increased the expression of pro-apoptotic Bcl-2-associated X protein (BAX) along with caspase-3. The synergistic effect was also confirmed using a 5-FU-resistant Hep3B mouse xenograft model in vivo. Conclusion: Nrf2 knockdown could improve the effect of As 2 O 3 on reversing drug resistance in 5-FU-resistant HCC cells. Keywords: arsenic trioxide, 5-fluorouracil, chemoresistance, hepatocellular carcinoma, Nrf2, HIF-1α Generally, chemotherapy resistance is associated with tumors containing cancer stem cells, a subpopulation of cells associated with undifferentiated tumors. 1 Chemotherapy resistance involves complex processes of cell death avoidance, DNA repair, and changes in drug metabolism. 2–4 Among the liver cancer risk factors, oxidative stress causes multidrug resistance. 5,6 Only patients with early hepatocellular carcinoma (HCC) can be treated with radical surgery, although this treatment has a poor long-term prognosis due to a high recurrence rate. Systemic therapy plays an increasingly important role in the treatment of HCC due to the complexity of the disease and several newly discovered therapeutic approaches. 7,8 Therefore, there is an urgent need to explore alternative treatments to improve the outcome. Although 5-fluorouracil (5-FU) is the preferred treatment for advanced HCC, it is associated with inherent and acquired drug resistance. Despite this, recent clinical trials suggest the combination of 5-FU with other drugs for the treatment of HCC is both safe and effective. 9–11 So, combination therapy using traditional chemotherapeutic agents or small molecule inhibitors selectively targeting tumor cells is a promising approach. HCC is characterized by excessive cell proliferation, which leads to local tissue hypoxia in the process of rapid growth, resulting in redox imbalance in the tumor cells. Hypoxia is one of the environmental factors that lead to chemical resistance. Hypoxia can alter the characteristics of tumor cells, leading to a certain degree of resistance to several chemotherapeutic drugs. Inducing endogenous antioxidant responses via nuclear factor erythroid 2-related factor (Nrf2) is important for regulating oxidative stress response. 12–14 Nrf2 plays an important role in resisting oxidative damage triggered by foreign chemicals and maintaining normal redox homeostasis in cells. And recent studies have confirmed that the loss of Nrf2 expression is an important anti-hypoxia mechanism. 15,16 Although the activation of Nrf2 may reduce cancer risk by inhibiting oxidative stress and promoting tumor inflammation, it is also associated with a poor prognosis. Arsenic trioxide (As 2 O 3 ) is the main active ingredient in indigo and arsenic. Our pr -Abstract Truncated-
oncology